GTx, Inc. (GTXI) - NASDAQ
Company Description
GTx, Inc. engages in the research and development of biopharmaceutical products. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate... More
Sector: Healthcare
Industry: Biotechnology
Country: United States